Brind.
  1. A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
  2. A company based in Sunnyvale sought FDA approval for therapies and held a conference in New York City.
  3. LENZ Therapeutics is engaged with the FDA regarding LNZ100.

Laboratoires Théa received an exclusive license for the drug LNZ100 from LENZ Therapeutics.

1 report, 0 independent Updated Jul 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Laboratoires Théa received an exclusive license for the drug LNZ100 from LENZ Therapeutics.

Keep exploring

Part of

LENZ Therapeutics is engaged with the FDA regarding LNZ100. All 2 developments

Within A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.

Coverage

Newest first; wire copies grouped
  • Unknown outlet